Immunocore (IMCR)
Immunocore Statistics
Share Statistics
Immunocore has 50.18M shares outstanding. The number of shares has increased by 0.12% in one year.
| 50.18M |
| 0.12% |
| 0.08% |
| 91.95% |
| n/a |
| 1,206 |
| 0.3% |
Short Selling Information
The latest short interest is 7.95M, so 15.83% of the outstanding shares have been sold short.
| 7.95M |
| 15.83% |
| 21.83% |
| 25.26 |
Valuation Ratios
The PE ratio is -28.87 and the forward PE ratio is -36.91. Immunocore's PEG ratio is 2.97.
| -28.87 |
| -36.91 |
| 4.75 |
| 2.2 |
| 4.09 |
| 70.6 |
| 2.97 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Immunocore.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.38, with a Debt / Equity ratio of 1.2.
| 4.38 |
| 4.36 |
| 1.2 |
| -6.14 |
| 20.72 |
| -3.74 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $629,212.98 |
| $-103,624.75 |
| 493 |
| 0.31 |
| 0.5 |
Taxes
| -1.85M |
| 3.49% |
Stock Price Statistics
The stock price has increased by -11.08% in the last 52 weeks. The beta is 0.83, so Immunocore's price volatility has been higher than the market average.
| 0.83 |
| -11.08% |
| 30.23 |
| 31.2 |
| 70.94 |
| 401,423 |
Income Statement
In the last 12 months, Immunocore had revenue of 310.2M and earned -51.09M in profits. Earnings per share was -1.02.
| 310.2M |
| 307.47M |
| -70.46M |
| -51.09M |
| -70.46M |
| -71.78M |
| -1.02 |
Balance Sheet
The company has 455.73M in cash and 432.72M in debt, giving a net cash position of 23.01M.
| 455.73M |
| 432.72M |
| 23.01M |
| -795.76M |
| 1.03B |
| 799.46M |
Cash Flow
In the last 12 months, operating cash flow was 26.06M and capital expenditures -5.17M, giving a free cash flow of 20.89M.
| 26.06M |
| -5.17M |
| 20.89M |
| 0.42 |
Margins
Gross margin is 99.12%, with operating and profit margins of -22.71% and -16.47%.
| 99.12% |
| -22.71% |
| -17.07% |
| -16.47% |
| -22.71% |
| -22.71% |
| 6.73% |
Dividends & Yields
IMCR does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for IMCR is $66, which is 73.9% higher than the current price. The consensus rating is "Buy".
| $66 |
| 73.9% |
| Buy |
| 16 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 1.5 |
| 4 |